Market News How it works Learn FAQ
| RCT 0.1382 81.60% | NU 11.97 -21.04% | TGL 0.2617 18.15% | EWZ 32.715 -23.19% | SRTM 0.3394 -21.12% | BBD 2.835 -30.34% | SHFS 0.0989 -25.30% | GCDT 0.1322 -24.93% | ITUB 7.368 -23.81% | NWGL 0.0817 -0.37% | CLRO 4.67 43.69% | XP 14.8623 -51.13% | AZTR 1.265 76.92% | RBNE 0.1664 -12.42% | PBR 21.535 -17.68% | SGRY 23.055 46.38% | SOXL 85.96 2.87% | TSLL 10.8899 11.58% | SPCX 147.535 0.03% | VALE 12.0045 -3.19% | SPRC 1.4499 33.02% | NVD 4.04 -3.58% | CRWV 54.96 1.34% | JBLU 2.2085 -15.87% | SOXS 51.01 -2.76% | INTC 87.29 0.38% | GPUS 0.1679 -0.59% | NVDA 215 1.92% | TSLA 394.1 5.88% | IREN 24.64 -1.06% | ABEV 2.7991 -15.18% | TQQQ 67.83 2.32% | RENT 2.9899 30.00% | NOK 8.46 3.93% | INTR 4.415 -38.60% | PBR-A 18.92 -19.59% | XTND 2.8083 58.66% | SQQQ 38.76 -2.32% | BITO 10.6402 -1.75% | LUCD 0.5437 32.29% | SPDN 8.495 -0.53% | VBIO 0.8098 -13.85% | SBS 4.765 -25.55% | XXII 0.0999 -49.47% | SID 0.9233 -21.75% | STNE 7.96 -30.66% | KORU 10.6 0.19% | WFF 0.0765 -4.38% | RWM 14.4501 -0.69% | TSLG 5.45 11.91%
MNMind Medicine (MindMed) Inc. logo

Mind Medicine (MindMed) Inc. (MNMD)

NASDAQ Capital Market · Currency in USD
$20.69 ▲ +0.09 (+0.44%)
As of Apr 2, 3:59 PM ET. Market open.

Summary

Previous Close
$20.60
Open
$20.15
Day's Range
$19.95 – $21.10
52 Week Range
$4.70 – $21.08
Volume
298,406
Avg. Volume
2,529,316
Market Cap
$1.56B
Beta (5Y Monthly)
2.62
PE Ratio (TTM)
--
EPS (TTM)
-$4.12
Earnings Date
--
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$20.00

Profile: Mind Medicine (MindMed) Inc.

Sector
Healthcare
Industry
Biotechnology
Full-time employees
74
CEO
Robert Barrow

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical firm dedicated to pioneering new treatments for various brain health conditions, encompassing psychiatric disorders, addiction, pain, and neurological ailments. Among its key pipeline assets is MM-120, currently undergoing Phase 2 clinical trials. This candidate is being investigated for its potential in addressing generalized anxiety disorder, attention deficit hyperactivity disorder (ADHD), and chronic pain.

Earnings

DateEst.Actual
Mar 5, 2026-$0.48-$0.51Miss
Nov 6, 2025-$0.52-$0.78Miss
Jul 31, 2025-$0.38-$0.50Miss
May 8, 2025-$0.36-$0.35Beat
Mar 6, 2025-$0.33-$0.41Miss
Nov 7, 2024-$0.28-$0.27Beat

Analyst view

Consensus price target
$20.00 ▼ -3.3%
Range $14.00 – $28.00
Rating: Buy
Buy 100% · Hold 0% · Sell 0%

Get free alerts on MNMD and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.